Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study. Curtin F, Vidal V, Bernard C, Kromminga A, Lang AB, Porchet H MAbs. 2016 Mar 30. PMID: 27030142. Abstract CommentRecommendBookmarkWatch